Target intelligence / Profile preview

NBPF member 21, pseudogene (NBPF21P)

Target
NBPF21P
Molecular classification
Other, Pseudogene, NBPF gene family
01

Overview

NBPF21P is a pseudogene of the neuroblastoma breakpoint family (NBPF), located at chromosome 3p22.2. Unlike most NBPF genes, which may have protein-coding capacity and possible biological or disease roles[1][2], NBPF21P is annotated as a pseudogene and is thus not considered a therapeutic target nor does it produce a functional protein. The NBPF gene family is noted for its paralogs and contains the NBPF/DUF1220 repeat domains, which have roles in human brain evolution and disease; however, NBPF21P, as a pseudogene, does not actively contribute to known biological functions or disease mechanisms[2][3]. There is no evidence NBPF21P is a receptor, enzyme, transporter, or therapeutic target, nor are there documented drugs, mechanism of action, biomarker utility, or safety information directly associated with it[2][3]. NBPF21P’s annotation as a pseudogene means it does not encode a functional protein and is not an active molecular target in therapeutic settings. Some confusion may arise due to the large number of NBPF family members, many of which are protein-coding genes implicated in neuroblastoma and other diseases, but NBPF21P is specifically classified as a pseudogene, and its biological or clinical relevance is null[2][3].

Other names
neuroblastoma breakpoint family member 21, pseudogeneNBPF21P

Beyond the preview

Go deeper on NBPF member 21, pseudogene (NBPF21P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NBPF member 21, pseudogene (NBPF21P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call